Vice President Yemi Osinbajo has welcomed efforts by a team of Nigerian scientists investigating the efficacy of Ivermectin drug in the treatment of COVID-19.
The team, which is composed of Nigerian scholars at home and abroad, has also submitted its report on the usefulness of the drug to the World Health Organisation.
The WHO has appointed a Peer Review expert from the United Kingdom.
According to him, “we have an opportunity here and I am so fascinated to hear this drug has been used in the treatment of River Blindness in this country.”
While commending the efforts of the team, Prof. Osinbajo added that with the report, Nigeria is at an advantage both in knowledge and availability of the drug, especially since Ivermectin has been found useful not only in the treatment of COVID-19, but also as a prophylactic medication.
He disclosed that the Federal Government will explore further ways to support the research for the benefit of Nigerians and humanity generally, while also advancing the effective funding of scientific research in the country.
The VP spoke after he was briefed virtually on the report by a team of scientists led by Prof. Femi Babalola, the Principal investigator, and Prof. Chris Bode, the Chief Medical Director of LUTH.